Methotrexate
NDC 63323-122, METHOTREXATE SODIUM, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-122
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040266
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHOTREXATE SODIUM1 g/1
Pharmacologic classes
Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-122-50 | 63323012250 | 1 VIAL in 1 CARTON (63323-122-50) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ec476b11-0b3c-4139-b1eb-a3daa76bc271Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-122
Use it
Look up 63323-122 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-122 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-122. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.